Haemoglobinopathies in greece: Prevention programme over the past 35 years

Indian Journal of Medical Research

Volumn 134, Issue 10, 2011, Pages 572-576

  Loukopoulos, Dimitris ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

Haemoglobinopathies; Inherited disorders of haemoglobin; Prenatal diagnosis; Prevention; Red cells; Thalassaemia

Indexed keywords

BETA GLOBIN; HEMOGLOBIN; IRON;

BLOOD TRANSFUSION; GREECE; HEALTH CARE COST; HEALTH CARE SYSTEM; HEALTH PROGRAM; HEALTH SERVICE; HEMOGLOBINOPATHY; HETEROZYGOTE; HUMAN; IRON CHELATION; PRENATAL DIAGNOSIS; PROPHYLAXIS; REVIEW; SICKLE CELL ANEMIA; THALASSEMIA; THALASSEMIA MAJOR;

ANEMIA, SICKLE CELL; FEMALE; GREECE; HETEROZYGOTE DETECTION; HUMANS; PREGNANCY; PRENATAL DIAGNOSIS; PUBLIC HEALTH; THALASSEMIA;

EID: 80555136702     PISSN: 09715916     EISSN: 09715916     Source Type: Journal    
DOI: None     Document Type: Review

References (21)

1. Angastiniotis M, Modell B, Englezos P, Boulyjenkov V. Prevention and control of the haemoglobinopathies. Bull World Health Organ 1995; 73: 375-86.
2. Modell B, Darlison M, Birgens H, Cario H, Faustino P, Giordano PC, et al. Epidemiology of globin disorders in Europe; an overview. Scand J Clin Lab Invest 2007; 67: 39-69.
3. Loukopoulos D. Hemoglobin variants and thalassemia in Greece. In: Winter WP, editor. Hemoglobin variants in human populations. Boca Raton: CRC Press, 1986. p. 165-80.
4. Loukopoulos D. Current status of thalassemia and the sickle cell syndromes in Greece. Semin Hematol 1996; 33: 76-86.
5. nd ed. Washington: World Bank; 2006. p. 663-80.
6. Caminopetros J. Recherches sur l'anémie érythroblastique infantile des peuples de la Mediterranée orientale. Etude anthopologique, étiologique et pathogénique. La transmission héreditaire de la maladie. (Observations regarding the infantile erythroblastic anemia occurring across the East Mediterranean populations; Anthropological, etiological and pathogenetic studies; the hereditary transmission of the disease). Annales de Medecine (in French) 1938; 43: 104-25. Ann Med 1938; 43: 104.
7. Malamos V, Fessas P, Stamatoyannopoulos G. Types of thalassaemia-trait carriers as revealed by a study of their incidence in Greece. Br J Haematol 1962; 8: 5-14.
8. Schizas N, Tegos C, Voutsadakis A, Arabatzis G, Angelopoulos P, Chrysanthopoulos K, et al. The frequency and distribution of β-thalassemia and abnormal hemoglobins in Greece. A study of 15,000 recruits. Hell Armed Forces Med Rev 1977; 11: (Suppl 1) 197-203.
9. Fessas P, Loukopoulos D, Kaltsoya-Tasiopoulou A. Prevention of thalassemia major of the haemoglobin syndromes in Greece and in other countries with high frequency. In: Loukopoulos D, editor. Prenatal diagnosis of thalassemia and the hemoglobinopathies. Boca Raton: CRC Press; 1988. p. 68-83.
10. Cao A, Furbetta M, Galanello R, Melis MA, Angius X, Ximene A, et al. Prevention of homozygous beta-thalassemia by carrier screening and prenatal diagnosis in Sardinia. Am J Hum Genet 1981; 33: 592-605.
11. Angastiniotis M, Kyriakidou S, Hadjiminas MG. How thalassemia was controlled in Cyprus. World Health Forum 1986; 7: 291-7.
12. WHO Working group. Hereditary Anaemias: genetic basis, clinical features, diagnosis and treatment. Bull World Health Organ 1982; 60: 643-60.
13. Thalassaemia and other haemoglobinopathies. Agenda item 13. 5.2. In: 59th World Health Assembly, 27 May 2006. EB118.R1. Available from: http://www.who.int/gb/ebwha/pdf_files/EBSS-EB118-2006-REC1/english/Res/r es-eb118_2006_rec1-en.pdf, accessed on February 6, 2008.
14. Kollia P, Karababa P, Sinopoulou K, Voskaridou E, Boussiou M, Papadakis M, et al. Beta-thalassaemia mutations and the underlying beta gene cluster haplotypes in the Greek population. Gene Geogr 1992; 6: 59-70.
15. Modell B, Ward RHT, Fairweather DVI. Effect of introducing antenatal diagnosis on reproductive behaviour of families at risk for thalassaemia major. Br Med J 1980; 1: 1347-9.
16. Aleporou-Marinou V, Sakarelou-Papapetrou N, Antsaklis A, Fessas P, Loukopoulos D. Prenatal diagnosis of thalassemia major in Greece; Evaluation of the first large series of attempts. Ann NY Acad Sci 1980; 344: 181-8.
17. Loukopoulos D, Karababa P, Antsaklis A, Panourgias J, Boussiou M, Karayannoppoulos K, et al. Prenatal diagnosis of thalassemia and HbS syndromes in Greece: an evaluation of 1500 cases. Ann N Y Acad Sci 1985; 445: 357-75.
18. Modell B, Petrou M, Layton M, Varnavides L, Slater C, Ward RH, et al. Audit of prenatal diagnosis for haemoglobin disorders in the United Kingdom: the first 20 years. Br Med J 1997; 315: 779-84.
19. Colah R, Gorakshakar A, Nadkarni A. Global burden, distribution and prevention of β-thalassemias and haemoglobin E disorders. Expert Rev Hematol 2010; 3: 103-17.
20. Cousens NE, Gaff CL, Metkalfe SA, Delatycki MB. Carrier screening for beta-thalassemia: a review of international practice. Eur J Hum Genet 2010; 18: 1077-83.
21. Giordano PC. Prospective and retrospective primary prevention of hemoglobinopathies in multiethnic societies. Clin Biochem 2009; 42: 1757-66.